⌂
Home
◈
Markets
▦
Screener
📈
Tools
◎
Portfolio
Skip to content
DFM General
5,851.39
−0.27%
FTSE ADX
9,783.24
−0.26%
TASI
10,123.62
−0.65%
QE Index
8,632.66
−0.01%
S&P 500
7,690.73
+0.41%
Nasdaq 100
29,529.34
+1.17%
Nifty 50
22,888.95
−1.11%
Sensex
73,852.90
−1.17%
KSE-100
165,966.09
−0.27%
DFM:EMIRATESNBD
AED 31.50
−0.25%
ADX:IHC
AED 352.00
−0.17%
SAU:2222
SAR 25.80
+0.00%
DSMD:QNBK
QAR 15.66
+2.29%
NAS:NVDA
$217.09
+1.38%
NYSE:TSM
$420.22
+1.84%
NSE:RELIANCE
₹1,202.00
−0.76%
KAR:OGDC
Rs 299.47
+0.12%
Gold
$4,140.81
−0.59%
Brent
$109.22
−0.54%
BTC
$81,966.87
−0.06%
ETH
$2,403.01
−0.18%
DFM General
5,851.39
−0.27%
FTSE ADX
9,783.24
−0.26%
TASI
10,123.62
−0.65%
QE Index
8,632.66
−0.01%
S&P 500
7,690.73
+0.41%
Nasdaq 100
29,529.34
+1.17%
Nifty 50
22,888.95
−1.11%
Sensex
73,852.90
−1.17%
KSE-100
165,966.09
−0.27%
DFM:EMIRATESNBD
AED 31.50
−0.25%
ADX:IHC
AED 352.00
−0.17%
SAU:2222
SAR 25.80
+0.00%
DSMD:QNBK
QAR 15.66
+2.29%
NAS:NVDA
$217.09
+1.38%
NYSE:TSM
$420.22
+1.84%
NSE:RELIANCE
₹1,202.00
−0.76%
KAR:OGDC
Rs 299.47
+0.12%
Gold
$4,140.81
−0.59%
Brent
$109.22
−0.54%
BTC
$81,966.87
−0.06%
ETH
$2,403.01
−0.18%
☰
Markets
▼
Stock markets
🇦🇪
UAE
DFM · ADX · DFM General
Closed
🇸🇦
Saudi Arabia
Tadawul · TASI
Closed
🇶🇦
Qatar
QSE · QE General
Closed
🇺🇸
United States
Nasdaq · NYSE · S&P 500
Closed
🇮🇳
India
NSE · BSE · Nifty 50
Closed
🇵🇰
Pakistan
PSX · KSE-100
Closed
Other assets
₿
Crypto
Ranked by volume · 24/7
🥇
Gold, FX & economy
Dubai gold, AED crosses, rates
◫
ETFs
Index, sector and gold funds
Explore
▦
Market map
Every market as a heatmap
📅
Calendar & IPOs
Earnings, dividends, listings, releases
⌁
Options flow · Ownership · Politics
US filings and tapes
Screener
▼
⚲
Stock screener
All six markets, one row per company
★
Ready-made screens
Starting points with a point of view
📁
My saved screens
Saved rules with alerts on new matches
⇄
Compare
Up to five, side by side
Crypto
Tools
▼
📈
Charting
Drawings, indicators, replay
▶
Strategy Maker
Write a rule, test it on history
⇄
Compare
Side by side
🔔
Alerts
Price, earnings, screens, strategies
News
Portfolio
⌕
AED
USD
SAR
QAR
INR
PKR
GBP
EUR
KWD
OMR
BHD
☆
♢
☾
Sign in
Create account
👤
Markets
›
India
› NSE
› BIOCON
B
Biocon Ltd
NSE:BIOCON
Healthcare
NSE:CNX200
NSE:CNX500
—
—
At close · Market cap
—
· Next earnings
Thu 5 Nov
☆
Watch
🔔
Alert
⇄
Compare
▶
Test a strategy
✦
AI read
Overview
Chart
Financials
Valuation
Forecasts
Dividends
News
Profile
Biocon Ltd · News · TradingHolo
BIOCON news
Headlines tagged to this company
BU
Biocon Secures Licensed Launch Dates For Pebrilzo Following Genentech Patent Settlement
Businessworld · 4 d ago
RE
Biocon settles Roche's US patent lawsuit over proposed breast-cancer drug copy
Reuters · 5 d ago
BU
Biocon gets launch clarity for breast cancer biosimilar after Genentech deal
Business Line · 5 d ago
BU
Biocon inks global patent settlement pact with Genentech for breast cancer drug Pebrilzo
Business Line · 6 d ago
CN
Biocon settles licence agreement with Genetech for cancer treatment drug — Check earliest secured launch dates
CNBC TV18 · 6 d ago
RE
Biocon Enters Global Settlement And License Agreement With Genentech For Pebrilzo
Reuters · 6 d ago
BU
Sunil Bharti Mittal Conferred France’s Legion Of Honour By Macron
Businessworld · 7 d ago
BU
October 12: Two dozen stocks, including Lenskart, Everyday Ind, SJS, Authum, Chemplast, Bajel Projects will remain in focus
Business Line · 8 d ago
EC
'Indian Pharma's Risk Aversion Holding Back Innovation'
Economic Times · 9 d ago
EC
'Pharma Industry must Take Risks'
Economic Times · 9 d ago
MI
CX Partners-backed Veeda Lifesciences eyes majority stake sale at upto $400 million valuation
Mint · 13 d ago
MI
True North picks up $50-60 mn stake in IPO-bound InMobi
Mint · 24 d ago
BU
Biocon Malaysia gets UK MHRA approval for new drug product fill-finish unit for insulins
Business Line · 24 d ago
CN
Biocon Malaysia arm gets UK regulator approval for Semglee fill finish unit
cnbctv · 25 d ago
MO
Biocon block deals: True North affiliate offloads Rs 638 crore worth shares; Citi, WhiteOak, SBI MF, Kotak Mahindra AMC among buyers
moneycontrol · 40 d ago
MO
Biocon shares rise 3% after stake sale in Rs 635-cr block deal; company eyes $1 billion biosimilars revenue
moneycontrol · 41 d ago
CN
Biocon shares gain nearly 3% after equity worth ₹630 crore changes hands in block deal
cnbctv · 41 d ago
CN
Biocon Block Deal: Active Pine likely to sell 1.66 crore shares at ₹385 per share
cnbctv · 41 d ago
CN
Biocon sees double-digit biosimilars growth continuing, targets mid-20% margins
cnbctv · 41 d ago
MO
Biocon shares rise 1.4% after 10-year Pertuzumab partnership in Brazil
moneycontrol · 42 d ago
More news →